Skip to main content
. 2020 Jan 30;8(2):195–204. doi: 10.1016/j.esxm.2019.12.002

Table 4.

Urologists' treatment of ED in patients with both ED and CVD in different group

Characteristics Whether to use a good life style to treat ED
Which was the treatment method of PDE5i
Whether to do penile implantation in intractable patients with ED
Whether to treat CVD in patients with both ED and CVD
Whether concerning about the use of PDE5i in patients with CVD
Whether to focus on CVD changes in the follow-up of patients with ED
Yes (n = 279) No (n = 124) On regular (n = 253) On demand (n = 150) Yes (n = 226) No (n = 117) Yes (n = 355) No (n = 58) Yes (n = 304) No (n = 99) Yes (n = 367) No (n = 46)
Age (years old)
 ≤40 P = 1.000 P = 1.000 P = 1.000 P = .055 P = .897 P = .009
 >40
Gender
 Male P = .222 P = .155 P = .706 P = .334 P = .663 P = .012
 Female
Professional years (years)
 ≤10 P = .710 P = 1.000 P = 1.000 P = .287 P = .692 P = .231
 >10
Educational background
 Under bachelor's degree P = .075 P = .507 P = .445 P = .621 P = .573 P = .101
 Bachelor's degree
 Postgraduate degree
 Doctoral degree
Level of hospital
 Community hospital P = .036 P = .253 P = .734 P = .032 P = .337 P = .002
 Secondary hospital
 Tertiary hospital

CVD = cardiovascular disease; ED = erectile dysfunction; PDE5i =phosphodiesterase type 5 inhibitor.